STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Privia Health Group, Inc. Stock Price, News & Analysis

PRVA Nasdaq

Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.

Privia Health Group, Inc. (PRVA) delivers technology-enabled physician partnership solutions transforming healthcare delivery. This news hub provides investors and industry observers with essential updates on the company's operational developments and strategic direction.

Access timely PRVA press releases covering earnings announcements, value-based care initiatives, and technology partnerships. Our curated collection helps stakeholders track:

• Financial Updates: Quarterly results and SEC filings
• Operational Milestones: Practice network expansions and platform enhancements
• Strategic Collaborations: Health system partnerships and technology integrations
• Industry Recognition: Awards and quality care achievements

Bookmark this page for objective reporting on PRVA's physician enablement strategies and cloud-based healthcare solutions. Verify compliance updates and leadership changes through our maintained news archive.

Rhea-AI Summary

ARLINGTON, Va., Nov. 28, 2022 – Privia Health Group (Nasdaq: PRVA) will participate in a fireside chat Q&A session at the 34th Annual Piper Sandler Healthcare Conference on November 30, 2022, at 10:00 am ET. The live webcast and replay will be available on their investor relations page.

Privia Health is a technology-driven physician enablement company that partners with medical groups and health systems to enhance practice efficiency and patient care, focusing on high-value healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
conferences
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) has announced the pricing of an underwritten public offering of 5,000,000 shares of common stock at $23.50 per share, with an option for underwriters to purchase an additional 750,000 shares. The offering is set to close on November 21, 2022. Notably, the company will not receive any proceeds from this secondary offering. Goldman Sachs & Co. LLC leads the underwriting team, which includes Credit Suisse, Jefferies, and others. The offering is detailed in a prospectus filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
none
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) announced a public offering of 5,000,000 shares of common stock by certain selling stockholders, with an option for underwriters to buy an additional 750,000 shares. The Company will not receive any proceeds from this offering, as costs will be borne by the selling stockholders. Goldman Sachs is leading the offering, which is under an already effective shelf registration statement filed with the SEC. Forward-looking statements highlight uncertainties surrounding the completion of the offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.46%
Tags
none
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) announced the resignation of Jeff Butler from its Board of Directors and Compliance Committee, effective immediately. Butler, a co-founder, stated his decision stems from confidence in the company's strength after 15 years. CEO Shawn Morris expressed gratitude for Butler's dedication and service. Privia Health is a technology-driven physician enablement company focused on optimizing healthcare delivery and improving patient experiences through innovative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
management
-
Rhea-AI Summary

Privia Health Group, Inc. reported strong Q3 2022 results, with total revenue reaching $342.9 million, a 36.3% increase from the previous year. The company achieved a net income of $1.6 million, or $0.01 per share, compared to a net loss of $(9.1) million in Q3 2021. Key metrics include a 52.4% rise in practice collections and a 27.2% increase in implemented providers. Additionally, the company announced new partnerships with health systems in North Carolina and Ohio, aiming to enhance its market reach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.93%
Tags
-
Rhea-AI Summary

Privia Health (Nasdaq: PRVA) announces a strategic partnership with Novant Health Enterprises to establish Privia Medical Group – North Carolina. This venture aims to enhance support for independent providers and facilitate a transition to value-based care through a clinically integrated network (CIN) model. The partnership emphasizes the optimization of practice operations and improved patient care experiences using Privia's innovative platform. New providers will benefit from technology solutions that alleviate administrative burdens and enhance collaboration in patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.87%
Tags
partnership
Rhea-AI Summary

ARLINGTON, Va., Oct. 06, 2022 – Privia Health Group, Inc. (Nasdaq: PRVA) will release its financial results for the third quarter and nine months ending September 30, 2022, before market opening on November 10, 2022. The press release will be available by 7:00 am ET on the Company's Investor Relations website. Management will host a conference call at 8:30 am ET on the same day to discuss performance and future outlook. Investors can access the call via live webcast, with a replay available shortly after.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
conferences earnings
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) will participate in a "fireside chat" Q&A session at the 2022 Global Healthcare Conference on September 13, 2022, at 9:05 AM ET. The event will feature the management team addressing key topics in healthcare. A live webcast, replay, and slide presentation will be accessible via their investor relations site. Privia Health is a tech-driven firm that enhances physician practices and patient experiences through cloud-based solutions, ensuring improved healthcare outcomes and cost efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
conferences
-
Rhea-AI Summary

Privia Health (Nasdaq: PRVA) and OhioHealth have announced a non-binding memorandum of understanding to establish a strategic partnership aimed at launching a medical group for independent providers in Ohio. This collaboration will enhance OhioHealth’s existing clinically integrated network (CIN) and offer an alternative for physicians wishing to maintain their independence. The anticipated new medical group will utilize Privia's technology platform to improve operational efficiency and support value-based care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.25%
Tags
none
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) announced its Accountable Care Organizations (ACOs) achieved $99.9 million in shared savings through the Medicare Shared Savings Program (MSSP) for 2021. With over 112,000 Medicare beneficiaries served, Privia's ACOs demonstrated 15% lower expenditures than the median MSSP ACO and 24% lower than total Fee for Service Medicare. Since 2014, they have accumulated over $740 million in shared savings. The technologies and care coordination efforts contributed to a quality score of 93%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.74%
Tags
none

FAQ

What is the current stock price of Privia Health Group (PRVA)?

The current stock price of Privia Health Group (PRVA) is $23.22 as of November 17, 2025.

What is the market cap of Privia Health Group (PRVA)?

The market cap of Privia Health Group (PRVA) is approximately 2.9B.
Privia Health Group, Inc.

Nasdaq:PRVA

PRVA Rankings

PRVA Stock Data

2.88B
114.82M
7.08%
97.06%
2.41%
Health Information Services
Services-health Services
Link
United States
ARLINGTON